A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

Pfeffer, Marc A., Burdmann, Emmanuel A., Chen, Chao-Yin, Cooper, Mark E., de Zeeuw, Dick, Eckardt, Kai-Uwe, Feyzi, Jan M., Ivanovich, Peter, Kewalramani, Reshma, Levey, Andrew S., Lewis, Eldrin F., McGill, Janet B., McMurray, John J.V., Parfrey, Patrick, Parving, Hans-Henrik, Remuzzi, Giuseppe, Singh, Ajay K., Solomon, Scott D., Toto, Robert·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0907845

Cited by (1,000)

Items 701–800 of 1,000

RBC Transfusions Among Hemodialysis Patients (1999-2010): Influence of Hemoglobin Concentrations Below 10 g/dL
David T. Gilbertson, Keri L. Monda, Brian D. Bradbury, Allan J. Collins · 2013 · American Journal of Kidney Diseases
Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial
Emmanuel Villar, Michel M Lièvre, Michèle Kessler, Vincent Lemaître, Éric Alamartine, Michel Rodier, Maud François, Philippe Zaoui, Olivier P. Moranne, Gabriel J. Choukroun et al. · 2011 · Journal of Diabetes and its Complications
Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Jacob Allen Udell, Benjamin M. Scirica, Eugene Braunwald, Itamar Raz, Philippe Gabríel Steg, Jaime A. Davidson, Boaz Hirshberg, Deepak L. Bhatt · 2012 · Clinical Cardiology
Action plan for optimizing the design of clinical trials in chronic kidney disease
Vlado Perkovic, Jonathan C. Craig, Worawon Chailimpamontree, Caroline S. Fox, Guillermo García-García, Mohammed Benghanem Gharbi, Meg Jardine, Ikechi Gareth Okpechi, Neesh Pannu, Bénédicte Stengel et al. · 2017 · Kidney International Supplements
The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary Era
Fredric O. Finkelstein, Susan H. Finkelstein · 2019 · Advances in Chronic Kidney Disease
Prevalence and determinants of anemia in the immediate postkidney transplant period
Ruben Poesen, Bert Bammens, Kathleen J. Claes, Dirk R. J. Kuypers, Yves F. Ch. Vanrenterghem, Diethard R.L. Monbaliu, Pieter Evenepoel · 2011 · Transplant International
Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment?
Roberto Scarpioni, Marco Ricardi, Luigi Melfa, Luciano Cristinelli · 2010 · Cardiovascular Therapeutics
Endogenous Plasma Erythropoietin, Cardiovascular Mortality and All-Cause Mortality in Renal Transplant Recipients
Steef J. Sinkeler, Dorien M. Zelle, Jaap J. Homan van der Heide, Rijk O. B. Gans, Gerjan Navis, Stephan J. L. Bakker · 2011 · American Journal of Transplantation
Blood Volume Measurements in Patients With Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing Anemia
Bassel Noumi, Sergio Luis Teruya, Say Salomon, Stephen T. Helmke, Mathew S. Maurer · 2011 · Congestive Heart Failure
2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA)
Kevin Damman, Jozine M. ter Maaten, Kaitlin J. Mayne, Davide Bolignano, Elizabeth M Brown, Bruno R. da Costa, Anna G. Dagre, Ron T. Gansevoort, Cristina Gavina, Andreas Goette et al. · 2026 · European Heart Journal
Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins
Takeshi Hasegawa, Junhui Zhao, Douglas S. Fuller, Brian A. Bieber, Jarcy Zee, Hal Morgenstern, Norio Hanafusa, Masaomi Nangaku · 2017 · American Journal of Nephrology
Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study
Yan Chen, Leila R. Zelnick, Matthew P. Huber, Ke Wang, Nisha Bansal, Andrew N. Hoofnagle, Rajan K. Paranji, Susan R. Heckbert, Noel S. Weiss, Alan S. Go et al. · 2021 · American Journal of Kidney Diseases
Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero, Mohammad Urooj Zafar, Juan J. Badimón · 2021 · Cardiovascular Drugs and Therapy
Prevalence of anemia and its predictors among patients with chronic kidney disease admitted to a teaching hospital in Ethiopia: A hospital-based cross-sectional study
Filagot Bishaw, Maekel Belay, Gashahun Mekonnen Dissassa, Bezawit Birhanu, Abinet Abebe · 2023 · Medicine
Influence of Anemia on Patient and Graft Survival After Renal Transplantation
Valérie Garrigue, Ilan Szwarc, Magali Giral, Jean‐Paul Soulillou, Christophe M. Legendre, Henri Kreis, Michèle Kessler, Marc Ladrière, Nassim Kamar, Lionel P. E. Rostaing et al. · 2013 · Transplantation
Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients
Angie Nishio, Bed P. Chhatkuli, Jennie Z. Ma, Kambiz Kalantari · 2013 · Blood Purification
The clinical status and survival in elderly dialysis: example of the oldest region of France
Florence Glaudet, Carine Achard Hottelart, Julien Allard, Vincent Allot, Frédérique Bocquentin, Rémy Boudet, B. Champtiaux, Jean Pierre Charmes, Monica Ciobotaru, Zara Dickson et al. · 2013 · BMC Nephrology
Association of High-Sensitivity Cardiac Troponin T and Natriuretic Peptide With Incident ESRD: The Atherosclerosis Risk in Communities (ARIC) Study
Yuhree Kim, Kunihiro Matsushita, Yingying Sang, Morgan Erika Grams, Hicham Skali, Amil M. Shah, Ron Cornelis Hoogeveen, Scott David Solomon, Christie Mitchell Ballantyne, Josef Coresh · 2014 · American Journal of Kidney Diseases
Effect of Facility-Level Hemoglobin Concentration on Dialysis Patient Risk of Transfusion
Allan J. Collins, Keri L. Monda, Julia T. Molony, Suying Li, David T. Gilbertson, Brian D. Bradbury · 2013 · American Journal of Kidney Diseases
Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
Heide A. Stirnadel-Farrant, Jiacong Luo, Lata Kler, Borut Čižman, Delyth Jones, Steven M. Brunelli, Alexander R. Cobitz · 2018 · BMC Nephrology
The effects of hyperglycaemia on peri-implant tissues after osseointegration
Seiya Yamazaki, Chihiro Masaki, Tomotaka Nodai, Shintaro Tsuka, Akiko Tamura, Taro Mukaibo, Yusuke Kondo, Kentaro Ono, Ryuji Hosokawa · 2019 · Journal of Prosthodontic Research
Management of Anemia in Nondialysis Chronic Kidney Disease: Current Recommendations, Real-World Practice, and Patient Perspectives
Murilo Henrique Guedes, Bruce M. Robinson, Gregorio T. Obrador, Allison Tong, Ronald L. Pisoni, Roberto Pecoits‐Filho · 2020 · Kidney360
Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer D. Lifschitz, Itzchak N. Slotki, Daniel Bitran, Daniel Lyon Fink · 2014 · Clinical Journal of the American Society of Nephrology
A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry
T. Steinmetz, Uwe Totzke, Michael Schweigert, J. Mittermüller, S. Nawka, Hans Tesch, Matthias Groschek, Ulrike Söling, E. Hellebrand, Antonis Georg Tsamaloukas · 2010 · European Journal of Cancer Care
Against TREATing All Patients Alike
Wolfgang C. Winkelmayer · 2010 · Journal of the American Society of Nephrology
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Sunil Bhandari · 2011 · Therapeutics and Clinical Risk Management
Molidustat for the treatment of renal anaemia in patients with dialysis-dependent chronic kidney disease: design and rationale of three phase III studies
Tadao Akizawa, Megumi Taguchi, Yoshimi Matsuda, Kazuma Iekushi, Takashi Yamada, Hiroyasu Yamamoto · 2019 · BMJ Open
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease
Roberto Minutolo, Carlo Garofalo, Paolo Chiodini, Filippo Aucella, Lucia Del Vecchio, Francesco Locatelli, Francesco Scaglione, Luca De Nicola · 2020 · Nephrology Dialysis Transplantation
Association between anemia and mortality in hemodialysis patients is modified by the presence of diabetes
Yukio Maruyama, Eiichiro Kanda, Kan Kikuchi, Masanori Abe, Ikuto Masakane, Takashi Yokoo, Kosaku Nitta · 2021 · Journal of Nephrology
The role of roxadustat in chronic kidney disease patients complicated with anemia
Jie Liu, Fan Yang, Yousuf Abdulkarim Waheed, Shulin Li, Kun Liu, Xinglei Zhou · 2023 · The Korean Journal of Internal Medicine
Patient Blood Management, Anemia, and Transfusion Optimization Across Surgical Specialties
Michael E. Kiyatkin, Domagoj Mladinov, Mary Jarzebowski, Matthew A. Warner · 2023 · Anesthesiology Clinics
Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large‐Scale Cohort Study ( C o‐ JET study)
Tadao Akizawa, Akira Saitō, Fumitake Gejyo, Masashi Suzuki, Yoshiki Nishizawà, Yasuhiko Tomino, Yoshiharu Tsubakihara, Takashi Akiba, Hideki Hirakata, Yuzo Watanabe et al. · 2013 · Therapeutic Apheresis and Dialysis
Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm
Hicham Skali, Julie Lin, Marc A. Pfeffer, Chao-Yin Chen, Mark Emmanuel Cooper, John J.V. McMurray, Allen R. Nissenson, Giuseppe Remuzzi, Jérôme Rossert, Patrick S. Parfrey et al. · 2012 · American Journal of Kidney Diseases
Achieving glycemic control in patients with type 2 diabetes and renal impairment
Angelo Avogaro, Guntram Schernthaner · 2012 · Acta Diabetologica
Approach to the Patient with Type 2 Diabetes and Progressive Kidney Disease
Elizabeth R. Seaquist, Hassan N. Ibrahim · 2010 · The Journal of Clinical Endocrinology & Metabolism
Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care
Nimesh S. A. Patel, Kiran K. Nandra, Christoph Thiemermann · 2012 · Critical Care
Incidence of symptomatic stroke and cancer in chronic kidney disease patients treated with epoetins
Enyu Imai, Ryohei Yamamoto, Hiromichi Suzuki, Tsuyoshi Watanabe · 2010 · Clinical and Experimental Nephrology
Increased hepcidin-25 and Erythropoietin Responsiveness in Patients With cardio–renal Anemia Syndrome
Akihiko Kato · 2010 · Future Cardiology
Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology
Alberto Ortíz · 2015 · Clinical Kidney Journal
Hematologic Aspects of Kidney Disease
Carlo Brugnara, Kai‐Uwe Eckardt · 2012 · Elsevier eBooks
Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case–control study
Émilie René, Hind H. Lazrak, Louis‐Philippe Laurin, Naoual Elftouh, Michel Vallée, Jean‐Philippe Lafrance · 2016 · Nephrology Dialysis Transplantation
Adverse safety events in patients with Chronic Kidney Disease (CKD)
Ada Ibe Offurum, Lee-Ann Wagner, Tanisha Gooden · 2016 · Expert Opinion on Drug Safety
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD
David M. Charytan, Scott David Solomon, Peter T. Ivanovich, Giuseppe Remuzzi, Mark Emmanuel Cooper, Janet B. McGill, Hans‐Henrik Parving, Patrick S. Parfrey, Ajay K. Singh, Emmanuel A. Burdmann et al. · 2017 · American Journal of Kidney Diseases
Translational science in chronic kidney disease
María Dolores Sánchez-Niño, Ana Belen Sanz, Adrian Mario Ramos, Marta Ruiz‐Ortega, Alberto Ortíz · 2017 · Clinical Science
Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation
Amber O. Molnar, Manish M. Sood · 2017 · Seminars in Dialysis
The efficacy and safety of roxadustat treatment for anemia in patients with kidney disease: a meta-analysis and systematic review
Suhui Qie, Ning Jiao, Kunfeng Duan, Jingxin Li, Yang Liu, Guoqiang Liu · 2021 · International Urology and Nephrology
Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus
2012 · Kidney International Supplements
Recombinant Human Erythropoietin Suppresses Endothelial Cell Apoptosis and Reduces the Ratio of Bax to Bcl-2 Proteins in the Aortas of Apolipoprotein E–Deficient Mice
Jeffrey S. Warren, Ying Zhao, Raymond L. Yung, Anjali Desai · 2011 · Journal of Cardiovascular Pharmacology
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
Giovanni FM Strippoli · 2010 · Trials
Bundled-Rate Legislation for Medicare Reimbursement for Dialysis Services
Chaim Charytan · 2010 · Clinical Journal of the American Society of Nephrology
Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy
Christina Antoniadou, Efstratios Gavriilidis, Konstantinos Ritis, Dimitrios Tsilingiris · 2025 · Metabolism Open
Anemia Management in the Cardiorenal Patient: A Nephrological Perspective
María Marqués, José María Portolés, Marta Cobo Marcos, José Luis Gorriz, Julio E. Núñez, Aleix Cases · 2025 · Journal of the American Heart Association
Anemia among Chinese patients with chronic kidney disease and its association with quality of life - results from the Chinese cohort study of chronic kidney disease (C-STRIDE)
the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE), Yan Shen, Jinwei Wang, Jing Yuan, Yang Li, Fangfang Yu, Xiaolei Wang, Ming‐Hui Zhao, Luxia Zhang, Yan Zha · 2021 · BMC Nephrology
The Perioperative Surgical Home, Enhanced Recovery After Surgery and how integration of these models may improve care for medically complex patients
Tyrone G. Harrison, Paul Everett Ronksley, Matthew Thomas James, Mary Elizabeth Brindle, Shannon Marie Ruzycki, Michelle M. Graham, Andrew D. McRae, Kelly B. Zarnke, Deirdre McCaughey, Chad G. Ball et al. · 2021 · Canadian Journal of Surgery
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study
Frank Dellanna, Roland E. Winkler, Fuat Bozkurt, Volker J. J. Schettler, Suzanne Graf, N. Bockreiss, Danilo Fliser, on behalf of the MIRACEL Study Group · 2010 · International Journal of Clinical Practice
Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial
Vasily Belozeroff, Glenn Matthew Chertow, Christopher N. Graham, Bastian Dehmel, Patrick S. Parfrey, Andrew H. Briggs · 2015 · Value in Health
Association of Mean Weekly Epoetin Alfa Dose with Mortality Risk in a Retrospective Cohort Study of Medicare Hemodialysis Patients
Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins · 2011 · American Journal of Nephrology
Anemia en el anciano
Agustín Urrútia, Emilio Sacanella, Jordi Mascaró, Francesç Formiga · 2010 · Revista Española de Geriatría y Gerontología
Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study
Miho Tagawa, Takayuki Hamano, Hiroshi Nishi, Kenji Tsuchida, Norio Hanafusa, Atsushi Fukatsu, Kunitoshi Iseki, Yoshiharu Tsubakihara · 2014 · PLoS ONE
Defining, Treating, and Understanding Chronic Kidney Disease—A Complex Disorder
Dean Campbell, Matthew R. Weir · 2015 · Journal of Clinical Hypertension
Asialoerythropoietin, a Nonerythropoietic Derivative of Erythropoietin, Displays Broad Anti-Heart Failure Activity
Toshiaki Takeyama, Genzou Takemura, Hiromitsu Kanamori, Tomonori Kawaguchi, Atsushi Ogino, Takatomo Watanabe, Kentaro Morishita, Akiko Tsujimoto, Kazuko Goto, Rumi Maruyama et al. · 2012 · Circulation Heart Failure
Comparative effectiveness research: what is it and why do we need it in nephrology?
Tara I. Chang, Wolfgang C. Winkelmayer · 2012 · Nephrology Dialysis Transplantation
Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes
Sandy von Salisch, Martin Klar, Boris Thurisch, Jörg Bungert, Christof Dame · 2010 · Journal of Cellular and Molecular Medicine
Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD
Stephen L. Seliger, Kathleen M. Fox, Shravanthi R. Gandra, Brian D. Bradbury, Van Doren Hsu, Loreen D. Walker, Chiun‐Fang Chiou, Jeffrey Craig Fink · 2010 · Clinical Journal of the American Society of Nephrology
High Serum Erythropoietin Levels are Related to Heart Failure Development in Subjects from the General Population with Albuminuria: Data from PREVEND
Niels Grote Beverborg, Haye H. van der Wal, IJsbrand Thomas Klip, Adriaan A. Voors, Rudolf A. de Boer, Wiek H. van Gilst, Dirk Jan van Veldhuisen, Ron T. Gansevoort, Hans L. Hillege, Pim van der Harst et al. · 2016 · European Journal of Heart Failure
Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients
Stanislas Bataille, Marion Pelletier, Marion Sallée, Yvon Berland, Nathalie McKay, Ariane Duval, Stéphanie Gentile, Yosra Mouelhi, Philippe Brunet, Stéphane Burtey · 2017 · BMC Nephrology
The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation
Robert M. Califf, Gary L. Filerman, Richard K. Murray, Michael Rosenblatt · 2012 · NAM Perspectives
Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation
Jay B. Wish, Kai‐Uwe Eckardt, Csaba Pal Kovesdy, Steven N. Fishbane, Bruce Spinowitz, Jeffrey S. Berns · 2021 · American Journal of Kidney Diseases
Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?
Milton Packer, John G.F. Cleland · 2022 · Journal of Cardiac Failure
Medication Issues in Older Individuals With CKD
Dena E. Rifkin, Wolfgang C. Winkelmayer · 2010 · Advances in Chronic Kidney Disease
A role for the membrane proteome in human chronic kidney disease erythrocytes
Gloria Álvarez‐Llamas, Irene Zubiri, Aroa S. Maroto, Fernando de la Cuesta, María Posada-Ayala, Marta Martin‐Lorenzo, María G. Barderas, Beatriz Fernández‐Fernández, Ana Ramos, Alberto Ortíz et al. · 2012 · Translational research
Anemia in Chronic Kidney Disease: New Advances
Tejas V. Patel, Ajay K. Singh · 2010 · Heart Failure Clinics
Trends in anemia management in US hemodialysis patients 2004–2010
The DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators, Dana C. Miskulin, Jing Zhou, Navdeep Tangri, Karen Bandeen‐Roche, Courtney Cook, Patti L. Ephraim, Deidra C. Crews, Julia J. Scialla, Stephen M. Sozio et al. · 2013 · BMC Nephrology
A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats
Pierre E. Signore, Guangjie Guo, Zhihua Wei, Weihua Zhang, Al Lin, Ughetta del Balzo · 2021 · PLoS ONE
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
Javier Donate‐Correa, María Dolores Sánchez-Niño, Ainhoa González-Luis, Carla María Ferri, Alberto Martín-Olivera, Ernesto Martín‐Núñez, Beatriz Fernández‐Fernández, Víctor G. Tagua, Carmen Mora Fernández, Alberto Ortíz et al. · 2022 · Clinical Kidney Journal
Treatment Options for Anemia in Kidney Transplant Patients: A Review
Mario Bonomini, Lorenzo Di Liberato, Vittorio Sirolli · 2023 · Kidney Medicine
High Hemoglobin Levels Maintained by an Erythropoiesis‐Stimulating Agent Improve Renal Survival in Patients with Severe Renal Impairment
Yoshiharu Tsubakihara, Tadao Akizawa, Manabu Iwasaki, Ryutaro Shimazaki · 2015 · Therapeutic Apheresis and Dialysis
Expert consensus on management of diabetic patients with impairment of renal function
Fabrice Bonnet, E. Gauthier, Henri Gin, Samy Hadjadj, J.-M. Halimi, Thierry P. Hannedouche, Vincent Rigalleau, Dorothée Romand, Ronan Roussel, Philippe Zaoui · 2011 · Diabetes & Metabolism
Erythropoiesis-Stimulating Agents: Dose and Mortality Risk
Guido Bellinghieri, Carmela Giuseppina Condemi, Salvatore Saitta, Gianluca Trifirò, Sebastiano Gangemi, Vincenzo Savica, Michele Buemi, Domenico Santoro · 2014 · Journal of Renal Nutrition
Trends in Anemia Care in Older Patients Approaching End-Stage Renal Disease in the United States (1995-2010)
Wolfgang C. Winkelmayer, Aya Mitani, Benjamin Alan Goldstein, M. Alan Brookhart, Glenn Matthew Chertow · 2014 · JAMA Internal Medicine
Has Dialysis Payment Reform Led to Initial Racial Disparities in Anemia and Mineral Metabolism Management?
Marc N. Turenne, Elizabeth L. Cope, Shannon Porenta, Purna Mukhopadhyay, Douglas S. Fuller, Jeffrey Pearson, Claudia Dahlerus, Brett Lantz, Francesca Tentori, Bruce M. Robinson · 2014 · Journal of the American Society of Nephrology
Targeted erythropoietin selectively stimulates red blood cell expansion in vivo
Devin R. Burrill, Andyna Vernet, James J. Collins, Pamela A. Silver, Jeffrey C. Way · 2016 · Proceedings of the National Academy of Sciences
Consensus Document of the Spanish Society of Cardiology and the Spanish Society of Internal Medicine on the diagnosis and treatment of iron deficiency in heart failure
Nicolás Manito, J.M. Cerqueiro, Josep Comin Colet, José Manuel García‐Pinilla, Álvaro González Franco, Jordi Grau Amorós, Juan R. Peraira, Luís Manzano · 2016 · Revista Clínica Española (English Edition)
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
Hideki Kato, Masaomi Nangaku, Hideki Hirakata, Takashi Wada, Terumasa Hayashi, Hiroshi Satō, Yasushi Yamazaki, Takao Masaki, Tatsuo Kagimura, Hiroyasu Yamamoto et al. · 2017 · Clinical and Experimental Nephrology
α‑klotho and anemia in patients with chronic kidney disease patients: A new perspective (Review)
Yang Xu, Hao Yang Peng, Ben Ke · 2017 · Experimental and Therapeutic Medicine
Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients
Luciano A. Pedrini, Adam M. Zawada, Anke C. Winter, Jenny Pham, Gudrun Klein, Melanie Wolf, Astrid Feuersenger, Pio Ruggiero, Annalisa Feliciani, Carlo Barbieri et al. · 2019 · PLoS ONE
Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy
Dick de Zeeuw, Hiddo J.L. Heerspink · 2020 · Nephrology Dialysis Transplantation
Are all erythropoiesis-stimulating agents created equal?
Francesco Locatelli, Lucia Del Vecchio, Luca De Nicola, Roberto Minutolo · 2020 · Nephrology Dialysis Transplantation
Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence
José González‐Costello, Miguel Cainzos‐Achirica, Josep Lupón, Núria Farré, Pedro Moliner, Cristina Enjuanes, Marta de Antonio, Lara Fuentes, Carles Díez‐López, Antoni Bayés‐Genís et al. · 2020 · European Journal of Internal Medicine
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial
Ajay K. Singh, Allison Blackorby, Borut Čižman, Kevin Carroll, Alexander R. Cobitz, Rich Davies, Vivekanand Jha, Kirsten L. Johansen, Renato D. Lópes, Lata Kler et al. · 2021 · Nephrology Dialysis Transplantation
Cerebrovascular Complications of Anemia
Ana Catarina Fonseca, Daniela P. Silva, Joana Brioso Infante, José Manuel Ferro · 2021 · Current Neurology and Neuroscience Reports
Anaemia Management in Chronic Kidney Disease
Iain C. Macdougall · 2014 · Springer eBooks
The safety and efficacy of peginesatide in patients with CKD
Kai‐Uwe Eckardt · 2013 · Nature Reviews Nephrology
Deficiência de ferro na doença renal crônica
Hugo Abensur · 2010 · Revista Brasileira de Hematologia e Hemoterapia
Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels
Katherine A. Cappell, Sanatan Shreay, Zhun Cao, Helen Varker, Carly J. Paoli, Matthew D. Gitlin · 2014 · BMC Nephrology
Individualizing Decision-Making—Resurrecting the Doctor-Patient Relationship in the Anemia Debate
Rajiv Agarwal · 2010 · Clinical Journal of the American Society of Nephrology
Iron deficiency associates with deterioration in several symptoms independently from hemoglobin level among chronic hemodialysis patients
Shuta Motonishi, Kentaro Tanaka, Takashi Ozawa · 2018 · PLoS ONE
Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study)
MIRACLE-CKD Study Group, Terumasa Hayashi, Yukari Uemura, Michiko Kumagai, Masashi Kimpara, Hiroyuki Kanno, Yasuo Ohashi · 2018 · Clinical and Experimental Nephrology
A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients
Adeera Levin, Taylor Perry, Prathibha De Zoysa, Mhairi K. Sigrist, Karin H. Humphries, Mila Tang, Ognjenka Djurdjev · 2014 · BMC Cardiovascular Disorders
Tissue protection by erythropoietin: new findings in a moving field
Masaomi Nangaku · 2013 · Kidney International